191 related articles for article (PubMed ID: 29540831)
41. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
42. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
Bouallegue A; Vardatsikos G; Srivastava AK
Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
[TBL] [Abstract][Full Text] [Related]
43. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
44. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.
Fornaro M; Steger CA; Bennett AM; Wu JJ; Languino LR
Mol Biol Cell; 2000 Jul; 11(7):2235-49. PubMed ID: 10888665
[TBL] [Abstract][Full Text] [Related]
45. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
46. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor.
Shakibaei M; John T; De Souza P; Rahmanzadeh R; Merker HJ
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):615-23. PubMed ID: 10477272
[TBL] [Abstract][Full Text] [Related]
47. Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
Tsushima H; Morimoto S; Fujishiro M; Yoshida Y; Hayakawa K; Hirai T; Miyashita T; Ikeda K; Yamaji K; Takamori K; Takasaki Y; Sekigawa I; Tamura N
Autoimmunity; 2017 Aug; 50(5):329-335. PubMed ID: 28682648
[TBL] [Abstract][Full Text] [Related]
48. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC.
Tang H; Bai Y; Pan G; Wang X; Wei Y; Yang Z; Zhao J
Autoimmunity; 2018 Dec; 51(8):399-407. PubMed ID: 30604632
[TBL] [Abstract][Full Text] [Related]
50. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9.
Deng H; Lin Y; Badin M; Vasilcanu D; Strömberg T; Jernberg-Wiklund H; Sehat B; Larsson O
Biochem Biophys Res Commun; 2011 Jan; 404(2):667-71. PubMed ID: 21147068
[TBL] [Abstract][Full Text] [Related]
51. Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway.
Zhang J; Wen G; Sun L; Yuan W; Wang R; Zeng Q; Zhang G; Yu B
Oncol Rep; 2018 Nov; 40(5):2926-2934. PubMed ID: 30106122
[TBL] [Abstract][Full Text] [Related]
52. Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor.
Andersson S; D'Arcy P; Larsson O; Sehat B
Biochem Biophys Res Commun; 2009 Sep; 387(1):36-41. PubMed ID: 19545541
[TBL] [Abstract][Full Text] [Related]
53. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
Azar ZM; Mehdi MZ; Srivastava AK
Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541
[TBL] [Abstract][Full Text] [Related]
54. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like growth factor-I signaling in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Oncogene; 2004 Jan; 23(1):130-41. PubMed ID: 14712218
[TBL] [Abstract][Full Text] [Related]
56. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
57. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
Vishwamitra D; Curry CV; Alkan S; Song YH; Gallick GE; Kaseb AO; Shi P; Amin HM
Mol Cancer; 2015 Feb; 14():53. PubMed ID: 25884514
[TBL] [Abstract][Full Text] [Related]
58. SKOR1 mediates FER kinase-dependent invasive growth of breast cancer cells.
Sluimer LM; Bullock E; Rätze MAK; Enserink L; Overbeeke C; Hornsveld M; Brunton VG; Derksen PWB; Tavares S
J Cell Sci; 2023 Feb; 136(3):. PubMed ID: 36620935
[TBL] [Abstract][Full Text] [Related]
59. Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells.
Liu R; Tang W; Han X; Geng R; Wang C; Zhang Z
Oncol Lett; 2018 Nov; 16(5):5983-5991. PubMed ID: 30333869
[TBL] [Abstract][Full Text] [Related]
60. Fer kinase regulates cell migration through α-dystroglycan glycosylation.
Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M
Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
